Evercore Wealth Management’s Pacira BioSciences PCRX Stock Holding History

Evercore Wealth Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,409	Closed	-$260K	–	422
2022 Q1	$260K	Hold	3,409	–	–	﹤0.01%	378
2021 Q4	$205K	Buy	+3,409	New	+$188K	﹤0.01%	409
2021 Q3	–	Sell	-3,409	Closed	-$207K	–	427
2021 Q2	$207K	Hold	3,409	–	–	﹤0.01%	414
2021 Q1	$239K	Hold	3,409	–	–	﹤0.01%	403
2020 Q4	$204K	Hold	3,409	–	–	﹤0.01%	413
2020 Q3	$205K	Buy	+3,409	New	+$198K	0.01%	363
2018 Q1	–	Sell	-3,409	Closed	-$156K	–	673
2017 Q4	$156K	Hold	3,409	–	–	0.01%	399
2017 Q3	$128K	Hold	3,409	–	–	0.01%	422
2017 Q2	$163K	Hold	3,409	–	–	0.01%	395
2017 Q1	$155K	Hold	3,409	–	–	0.01%	412
2016 Q4	$110K	Hold	3,409	–	–	﹤0.01%	477
2016 Q3	$117K	Hold	3,409	–	–	﹤0.01%	456
2016 Q2	$115K	Hold	3,409	–	–	0.01%	438
2016 Q1	$181K	Hold	3,409	–	–	0.01%	377
2015 Q4	$262K	Sell	3,409 -1,000	-23%	-$56.6K	0.01%	328
2015 Q3	$181K	Hold	4,409	–	–	0.01%	397
2015 Q2	$312K	Sell	4,409 -1,000	-18%	-$78.8K	0.01%	346
2015 Q1	$481K	Sell	5,409 -400	-7%	-$40.6K	0.02%	282
2014 Q4	$515K	Sell	5,809 -800	-12%	-$75.7K	0.03%	231
2014 Q3	$641K	Sell	6,609 -5,973	-47%	-$581K	0.03%	230
2014 Q2	$1.16M	Sell	12,582 -1,500	-11%	-$114K	0.06%	173
2014 Q1	$986K	Buy	14,082 +7,582	+117%	+$516K	0.06%	188
2013 Q4	$374K	Buy	6,500 +1,500	+30%	+$78.9K	0.02%	299
2013 Q3	$240K	Hold	5,000	–	–	0.01%	381
2013 Q2	$145K	Buy	+5,000	New	+$145K	0.01%	439

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Evercore Wealth Management's PCRX Position: Q2 2022 in Review

Evercore Wealth Management sold out of Pacira BioSciences (PCRX) in Q2 2022, closing a stake of 3,409 shares — an estimated $260K sold.

Evercore Wealth Management first reported a position in PCRX in Q2 2013 and held it in 25 quarters. The position peaked at $1.16M in Q2 2014. 284 funds tracked by Wall St. Rank hold PCRX as of Q2 2022.

Evercore Wealth Management reported no remaining Pacira BioSciences position as of Q2 2022 after selling out during the quarter.
Evercore Wealth Management sold 3,409 Pacira BioSciences shares in Q2 2022, an estimated $260K.
Evercore Wealth Management first reported a position in Pacira BioSciences in Q2 2013 and held it in 25 quarters.
Evercore Wealth Management's Pacira BioSciences position peaked at $1.16M in Q2 2014.
284 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2022.

Based on Evercore Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.